Bolt Biotherapeutics, Inc. (BOLT) vs CNS Pharmaceuticals, Inc. (CNSP)
A side-by-side comparison of Bolt Biotherapeutics, Inc. and CNS Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLT
Bolt Biotherapeutics, Inc.
$3.59HealthcareDelayed quote: Oct 6, 2026, 11:33 AM EDT
CNSP
CNS Pharmaceuticals, Inc.
$5.36HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
Total return — BOLT vs CNSP
growth of $100 · dividends reinvested · last 6yBOLT -99.5% (-58.1%/yr)CNSP -100.0% (-89.0%/yr)BOLT compounded faster over this window
Log scale — wide-divergence pair
BOLT CNSP
BOLT vs CNSP: by the numbers
- •CNSP is the larger company ($8M vs $7M market cap).
- •Both run net losses; CNSP's is the smaller (0.00% vs -611.47% net margin).
Metrics side by side
Valuation
| Metric | BOLT | CNSP |
|---|---|---|
| P/S ratio | 1.47 | N/A |
| P/B ratio | 0.55 | 0.43 |
Profitability
| Metric | BOLT | CNSP |
|---|---|---|
| Gross margin | 80.62% | 0.00% |
| Operating margin | -450.07% | 0.00% |
| Net margin | -611.47% | 0.00% |
| ROE | -227.37% | -91.75% |
| ROIC | -90.17% | -92.94% |
Growth (annualized)
| Metric | BOLT | CNSP |
|---|---|---|
| Total return CAGR (5Y) | -57.61% | -91.63% |
Frequently asked
- How have BOLT and CNSP total returns compared?
- Over the past 5 years, BOLT delivered -57.61% and CNSP delivered -91.63% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.